Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Trial of Roflumilast in Asthma Management (TRIM)

ClinicalTrials.gov ID: NCT03532490

Public ClinicalTrials.gov record NCT03532490. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT03532490
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Johns Hopkins University
Other
Enrollment
38 participants

Conditions and interventions

Interventions

  • Roflumilast 500 Mcg Oral Tablet Drug
  • Placebo oral capsule Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2, 2018
Primary completion
Jul 29, 2021
Completion
Jul 29, 2021
Last update posted
Oct 5, 2022

2018 – 2021

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
University of Alabama Lung Health Center Birmingham Alabama 35294
University of Arizona Tucson Arizona 85724
University of Illinois at Chicago, Breathe Chicago Center Chicago Illinois 60608
Northwestern University Feinberg School of Medicine Chicago Illinois 60611
Mount Sinai Icahn School of Medicine New York New York 10029
Duke University Durham North Carolina 27705
University of Vermont Colchester Vermont 05446

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03532490, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 5, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03532490 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →